Funds and ETFs Mayinglong Pharmaceutical Group Co., LTD.

Equities

600993

CNE000001HN2

Pharmaceuticals

End-of-day quote Shanghai S.E. 06:00:00 2024-05-07 pm EDT 5-day change 1st Jan Change
28.82 CNY -0.62% Intraday chart for Mayinglong Pharmaceutical Group Co., LTD. +3.52% +19.19%

ETFs positioned on Mayinglong Pharmaceutical Group Co., LTD.

Name Weight AuM 1st Jan change Investor Rating
0.00% 0 M€ +3.45% -
Mayinglong Pharmaceutical Group Co., Ltd. is a China-based company, principally engaged in pharmaceutical production, retailing and wholesaling businesses. The Company's pharmaceutical products are classified as drugs for hemorrhoid, including diosmin tablets, suppositories, pastes and granules, among others; drugs for cough, including levodropropizine oral solution and compound glycyrrhiza oral solution, as well as drugs for skin injuries, including products such as erythromycin ointment. The Company also provides specialty drugs. The Company is also engaged in the production and distribution of eye cream products with the brand named Mayinglong BaBao, as well as the provision of hospital clinical service. The Company distributes its products mainly in domestic markets.
More about the company
  1. Stock Market
  2. Equities
  3. 600993 Stock
  4. Funds and ETFs Mayinglong Pharmaceutical Group Co., LTD.
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW